First implants for ELA's pacemaker and defibrillator:
This article was originally published in Clinica
Executive Summary
ELA Medical has announced the first implants of two of its cardiac devices. The Chorum 7434 VDDR pacemaker, which is indicated for isolated AV block with normal sinus function, has been implanted in Italy. Chorum will be launched after clinical evaluation in Europe ends in January 1998. The first implant of Defender II, ELA's second-generation, dual-chamber defibrillator, has been made at the University Hospital of Rennes in France. The world market for implantable cardiac defibrillators grew from $145 million in 1990 to $780 million in 1996.